valerates has been researched along with Hypercholesterolemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FREDRICKSON, DS; STEINBERG, D | 1 |
| Boberg, J; Hellsing, K; Lithell, H; Vessby, B; Werner, I | 1 |
| Grundy, SM | 1 |
| Koskinen, P; Lassila, R; Laustiola, K; Manninen, V; Pellinen, T | 1 |
| Elo, O; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Manninen, V | 1 |
| Krause, BR; Newton, RS | 1 |
3 trial(s) available for valerates and Hypercholesterolemia
| Article | Year |
|---|---|
Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Topics: Adipose Tissue; Adult; Aged; Body Weight; Clinical Trials as Topic; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Insulin; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Placebos; Triglycerides; Valerates; Xylenes | 1976 |
Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress.
Topics: Adult; Blood Platelets; Clinical Trials as Topic; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Physical Exertion; Platelet Aggregation; Thromboxane B2; Valerates | 1988 |
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Random Allocation; Risk Factors; Triglycerides; Valerates | 1987 |
3 other study(ies) available for valerates and Hypercholesterolemia
| Article | Year |
|---|---|
Failure of alpha-phenylbutyrate and beta-phenylvalerate in treatment of hypercholesterolemia.
Topics: Butyrates; Cholesterol; Humans; Hypercholesterolemia; Phenylbutyrates; Valerates | 1957 |
Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
Topics: Adult; Bile Acids and Salts; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates | 1988 |
Gemfibrozil treatment and the relationship between HDL cholesterol and apoE distribution in cholesterol-fed rats.
Topics: Animals; Apolipoproteins B; Apolipoproteins E; Cholesterol, Dietary; Cholesterol, HDL; Diet; Gemfibrozil; Hypercholesterolemia; Hypothyroidism; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Pentanoic Acids; Rats; Rats, Inbred Strains; Triglycerides; Valerates | 1986 |